1 Ocak 2020 Dergi makalesi Açık Erişim

Ozbagcivan, O.; Ozturk, T.; Akarsu, S.; Ilknur, T.; Fetil, E.

DataCite XML

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/11581</identifier>
  <creators>
    <creator>
      <creatorName>Ozbagcivan, O.</creatorName>
      <givenName>O.</givenName>
      <familyName>Ozbagcivan</familyName>
      <affiliation>Dokuz Eylul Univ, Fac Med, Dept Dermatol, TR-35340 Izmir, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Ozturk, T.</creatorName>
      <givenName>T.</givenName>
      <familyName>Ozturk</familyName>
      <affiliation>Dokuz Eylul Univ, Fac Med, Dept Ophthalmol, Izmir, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Akarsu, S.</creatorName>
      <givenName>S.</givenName>
      <familyName>Akarsu</familyName>
      <affiliation>Dokuz Eylul Univ, Fac Med, Dept Dermatol, TR-35340 Izmir, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Ilknur, T.</creatorName>
      <givenName>T.</givenName>
      <familyName>Ilknur</familyName>
      <affiliation>Dokuz Eylul Univ, Fac Med, Dept Dermatol, TR-35340 Izmir, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Fetil, E.</creatorName>
      <givenName>E.</givenName>
      <familyName>Fetil</familyName>
      <affiliation>Dokuz Eylul Univ, Fac Med, Dept Dermatol, TR-35340 Izmir, Turkey</affiliation>
    </creator>
  </creators>
  <titles>
    <title>Evaluation Of Metabolic Syndrome And Its Components In Patients With Rosacea: A Cross-Sectional, Case-Control Study</title>
  </titles>
  <publisher>Aperta</publisher>
  <publicationYear>2020</publicationYear>
  <dates>
    <date dateType="Issued">2020-01-01</date>
  </dates>
  <resourceType resourceTypeGeneral="Text">Journal article</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/11581</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.81043/aperta.11580</relatedIdentifier>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.81043/aperta.11581</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">Introduction: Previous studies have suggested an association between cardiovascular disease and rosacea. However, there is still a paucity of data regarding its association with metabolic syndrome (MetS). Methods: The components of MetS were evaluated in 100 rosacea patients and 100 controls. Results: MetS was determined in 44% of the rosacea patients and 35% of the controls. Although the difference was not statistically significant (p=0.193), rosacea patients were more likely to have dyslipidaemia (p&amp;lt;0.001), insulin resistance (p=0.035), hypertension (p=0.009), higher atherogenic index (p&amp;lt;0.001) and a higher hypercoagulability (p=0.025) and inflammatory state (p=0.003) compared to controls. Conclusion: The results of this study support that rosacea patients should be screened routinely for the components of MetS such as dyslipidaemia, insulin resistance, hypertension and other cardiovascular risk factors.</description>
  </descriptions>
</resource>